Skip to content
Search

Latest Stories

CCA members celebrate hitting 200,000 Pharmacy First consultations milestone

CCA members celebrate hitting 200,000 Pharmacy First consultations milestone
Along with the pharmacy first celebrations, the Company Chemists Association has also highlighted the urgent need for GP referrals 

Since its launch on January 31st, the Pharmacy First service by the Company Chemists Association (CCA) has achieved a significant milestone, completing over 200,000 consultations to date.

This milestone underscores the service's vital role in providing same-day NHS care through community pharmacies across England.


Recent analysis by the CCA has revealed a pressing need to bolster GP referrals, with disparities observed between different Integrated Care System (ICS) areas, resulting in what's described as a 'postcode lottery' for patients.

CCA Chief Executive, Malcolm Harrison, emphasised the importance of sustained funding for Pharmacy First beyond 2025, ensuring its availability for patients, community pharmacies, and the wider NHS.

Harrison stated, "The strong patient interest in the service and the stories we are hearing from the frontline show that Pharmacy First is here to stay."

In response to these findings, the CCA is calling on the next Government and NHS England to prioritize targeted public engagement campaigns to raise awareness of Pharmacy First.

They advocate for increased support and training for GP surgeries to enhance referral rates, citing successful strategies from higher-performing ICS areas.

Looking ahead, Harrison emphasised the need for collaborative efforts to explore opportunities for expanding the service, ultimately aiming to enhance patient access to primary care.

He remarked, "Expansion of Pharmacy First will only be possible if policymakers commit to fund Pharmacy First beyond 2025 – to give patients, pharmacy businesses, and the wider NHS confidence in the service."

The CCA's data collection methodology, involving anonymized and aggregated data from over 3,000 pharmacies, underscores the robustness of their findings.

However, it's noted that the consultation figures do not consider any gateway criteria, providing a comprehensive overview of patient engagement with the service.

As Pharmacy First continues to evolve, stakeholders are reminded of its crucial role in transforming healthcare delivery, promising greater accessibility and convenience for patients across England.

More For You

Pharmacist handing medicine to patient, NHS prescription cost freeze debate

Prescription charge will remain at £9.90

Pic credit: iStock

NPA calls for end to prescription charge after freeze announcement

The National Pharmacy Association (NPA) has asked for prescription charges to be completely removed despite the government announcing today that the charge will be frozen for the first time in three years.

Patients will continue paying £9.90 to collect their medication from a pharmacy.

Keep ReadingShow less
RPS launches new prescribing development programme for pharmacists

From 2026, every newly qualified pharmacist will be an independent prescriber

gettyimages

RPS unveils new training programme to enhance pharmacists’ prescribing skills

The Royal Pharmaceutical Society (RPS) has announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

The initiative comes ahead of the NHS mandate that every newly qualified pharmacist will be an independent prescriber by 2026 — a change set to transform the future of pharmacy practice.

Keep ReadingShow less
Varenicline promotes nicotine vaping cessation in young people

Researchers warn that e-cigarette use can increase risk for nicotine addiction,uptake of combusted tobacco and other substance use.

gettyimages

Anti-smoking pill varenicline may help young people quit vaping, new study suggests

Varenicline — a daily pill already offered through NHS Stop Smoking Services — could also support young people in quitting vaping, new research has suggested.

The medication, proven to be more effective than nicotine replacement gums or patches for smoking cessation, was shown to significantly boost vaping abstinence when combined with behavioural counselling in adolescents and young adults.

Keep ReadingShow less
Relying on blue inhalers alone can worsen asthma symptoms, warns MHRA

Patients are advised to use their preventer inhaler regularly, even if their asthma feels under control.

Pic credit: gettyimages

Overuse of blue inhalers can increase risk of severe asthma attacks, warns MHRA

The Medicines and Healthcare products Regulatory Agency (MHRA) is reminding asthma patients to use their preventer (anti-inflammatory) inhalers regularly as prescribed, rather than relying solely on their blue inhalers, also referred to as reliever inhalers.

“Without regular use of a preventer inhaler, symptoms could worsen and increase the risk of severe asthma attacks,” the MHRA warned.

Keep ReadingShow less
13 pharmacists achieve RPS core advanced credential with record pass rate

The latest successful cohort includes pharmacists from both England and Scotland.

Pic credit: Getty Images

13 more pharmacists achieve RPS core advanced credential - Highest pass rate yet

The Royal Pharmaceutical Society (RPS) has announced that 13 more pharmacists have successfully completed Core Advanced Credentialling as part of the latest assessment cohort —achieving a remarkable 93% pass rate, the highest to date.

This brings the total number of pharmacists awarded the RPS core advanced credential to 113 since the launch of the Core Advanced Curriculum in 2023, with successful candidates from GP, secondary care and community settings.

Keep ReadingShow less